Diff: Diabetes Mellitus
Comparing revision #2 (2024-01-01 05:19:35) with revision #3 (2026-06-22 05:34:12).
| Old | New |
|---|---|
'''Diabetes mellitus''' stands as a chronic medical condition characterised by heightened levels of blood glucose ([[hyperglycaemia]]) stemming from deficiencies in insulin secretion, insulin action, or a confluence of both factors. Insulin, a hormone manufactured by the pancreas, assumes a pivotal role in regulating blood sugar levels. Diabetes may precipitate various complications that impact diverse organ systems. Effective management involves lifestyle modifications, pharmaceutical interventions, and, in certain instances, insulin therapy. |
|
'''Diabetes mellitus''' is a chronic medical condition characterised by heightened levels of blood glucose ([[hyperglycaemia]]) stemming from deficiencies in insulin secretion, insulin action, or a confluence of both factors. Insulin, a hormone manufactured by the pancreas, assumes a pivotal role in regulating blood sugar levels. Diabetes may precipitate various complications that impact diverse organ systems. Effective management involves lifestyle modifications, pharmaceutical interventions, and, in certain instances, insulin therapy. |
|
== Classification == |
== Classification == |
=== Type 1 Diabetes: === |
=== Type 1 Diabetes: === |
* Autoimmune Pathogenesis: The immune system orchestrates an assault on and subsequent destruction of insulin-producing beta cells within the pancreas. |
* Autoimmune Pathogenesis: The immune system orchestrates an assault on and subsequent destruction of insulin-producing beta cells within the pancreas. |
* Insulin Dependency: Those afflicted with type 1 diabetes necessitate insulin for subsistence. |
* Insulin Dependency: Those afflicted with type 1 diabetes necessitate insulin for subsistence. |
* Onset: Typically diagnosed during childhood or adolescence. |
* Onset: Typically diagnosed during childhood or adolescence. |
=== Type 2 Diabetes: === |
=== Type 2 Diabetes: === |
* Insulin Resistance: Cells acquire resistance to insulin, while the pancreas may falter in producing an adequate insulin supply. |
* Insulin Resistance: Cells acquire resistance to insulin, while the pancreas may falter in producing an adequate insulin supply. |
* Lifestyle Correlates: Obesity, sedentary habits, and genetic predisposition contribute to type 2 diabetes. |
* Lifestyle Correlates: Obesity, sedentary habits, and genetic predisposition contribute to type 2 diabetes. |
* Onset in Adulthood: Frequently diagnosed in adults, though an escalating incidence is observable in the youthful demographic. |
* Onset in Adulthood: Frequently diagnosed in adults, though an escalating incidence is observable in the youthful demographic. |
=== Gestational Diabetes: === |
=== Gestational Diabetes: === |
* Pregnancy-Related Morbidity: Manifests during pregnancy and heightens the risk of later-life type 2 diabetes. |
* Pregnancy-Related Morbidity: Manifests during pregnancy and heightens the risk of later-life type 2 diabetes. |
* Glucose Intolerance: Elevation in blood glucose levels during gestation. |
* Glucose Intolerance: Elevation in blood glucose levels during gestation. |
== Symptoms == |
== Symptoms == |
* Polyuria: Augmented frequency of urination. |
* Polyuria: Augmented frequency of urination. |
* Polydipsia: Inordinate thirst. |
* Polydipsia: Inordinate thirst. |
* Polyphagia: Excessive hunger. |
* Polyphagia: Excessive hunger. |
* Unexplained Weight Loss: Persists despite an increased appetite. |
* Unexplained Weight Loss: Persists despite an increased appetite. |
== Diagnosis == |
== Diagnosis == |
* Fasting Blood Glucose Test: Measures blood glucose levels following an overnight fasting period. |
* Fasting Blood Glucose Test: Measures blood glucose levels following an overnight fasting period. |
* Oral Glucose Tolerance Test (OGTT): Assesses the body's capacity to manage a glucose load. |
* Oral Glucose Tolerance Test (OGTT): Assesses the body's capacity to manage a glucose load. |
* Haemoglobin A1c Test: Reflects mean blood glucose levels over the preceding 2-3 months. |
* Haemoglobin A1c Test: Reflects mean blood glucose levels over the preceding 2-3 months. |
== Complications == |
== Complications == |
=== Short-Term Complications: === |
=== Short-Term Complications: === |
* Hypoglycaemia: Reduced blood sugar levels, precipitating symptoms like dizziness and cognitive confusion. |
* Hypoglycaemia: Reduced blood sugar levels, precipitating symptoms like dizziness and cognitive confusion. |
* Hyperglycaemia: Elevated blood sugar levels, potentially instigating diabetic ketoacidosis (DKA). |
* Hyperglycaemia: Elevated blood sugar levels, potentially instigating diabetic ketoacidosis (DKA). |
=== Long-Term Complications: === |
=== Long-Term Complications: === |
* Cardiovascular Morbidity: Escalates susceptibility to cardiovascular maladies and cerebrovascular incidents. |
* Cardiovascular Morbidity: Escalates susceptibility to cardiovascular maladies and cerebrovascular incidents. |
* Nephropathy: Induces kidney impairment. |
* Nephropathy: Induces kidney impairment. |
* Retinopathy: Provokes ocular impairment, possibly culminating in blindness. |
* Retinopathy: Provokes ocular impairment, possibly culminating in blindness. |
* Neuropathy: Incites nerve damage, signifying symptoms of paraesthesia. |
* Neuropathy: Incites nerve damage, signifying symptoms of paraesthesia. |
* Foot Complications: Impaired circulation and neural damage amplify the vulnerability to infections and amputation risks. |
* Foot Complications: Impaired circulation and neural damage amplify the vulnerability to infections and amputation risks. |
== Management == |
== Management == |
* Lifestyle Interventions: Adoption of a wholesome diet, regular physical activity, and weight vigilance. |
* Lifestyle Interventions: Adoption of a wholesome diet, regular physical activity, and weight vigilance. |
* Pharmacological Modalities: Administration of oral hypoglycaemic agents or insulin therapy as deemed clinically appropriate. |
* Pharmacological Modalities: Administration of oral hypoglycaemic agents or insulin therapy as deemed clinically appropriate. |